Invited Speaker Presentation-TP53 alterations in myelodysplastic neoplasms & acute myeloid leukemia
27:49
Spotlight Symposium: GOAL Consortium
1:31:23
MDS CLASSIFICATION & PROGNOSIS
1:14:27
Major Treatment Decisions for Patients with Acute Myeloid Leukemia (AML)
51:02
25. Cancer 1
51:44
Flow cytometry in Chronic Myeloid Neoplasms: Current Recommendations and Challenges
13:46
Frequency and etiology of cytogenetically cryptic oncogenic fusions in pediatric AML
1:04:42
Clonal Hematopoiesis: Origins and Clinical Implications
32:32